+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lung Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 93 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5729108
Description Jump to:

Quick Summary:

In the evolving global landscape of the pharmaceutical industry, the Lung Cancer Drugs Market holds substantial potential for growth. This market is marked by innovations, advanced treatments, and an urgent need to curtail the global burden of lung cancer. This comprehensive report will serve as a strategic tool to stay informed and make sound business decisions. Gain competitive advantages by understanding the industry trends and key strategies of major players across different regions.

The report offers an in-depth analysis of supply, demand and pricing trends in North America, South America, Asia & Pacific, Europe, and MEA, with further insights into key countries like the United States, China, Japan, India, Germany, France, UK, and Brazil. Furthermore, it provides a comprehensive competitor analysis including company profiles, SWOT analysis, and market share details of major players like Regeneron Pharmaceuticals/Sanofi, Merck, Bristol-Myers Squibb, Roche, AstraZeneca, and Pfizer. Detailed insights into different types of lung cancer drugs such as cemiplimab, pembrolizumab, nivolumab, atezolizumab, durvalumab, avelumab and others are also included.

This report describes the global market size of Lung Cancer Drugs from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Lung Cancer Drugs as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • cemiplimab
  • pembrolizumab
  • nivolumab
  • atezolizumab
  • durvalumab
  • avelumab
  • Others

Companies Covered

  • Regeneron Pharmaceuticals/Sanofi
  • Merck
  • Bristol-Myers Squibb
  • Roche
  • AstraZeneca
  • Pfizer
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Lung Cancer Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Lung Cancer Drugs Market in North America (2019-2029)
8.1 Lung Cancer Drugs Market Size
8.2 Lung Cancer Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Lung Cancer Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Lung Cancer Drugs Market in South America (2019-2029)
9.1 Lung Cancer Drugs Market Size
9.2 Lung Cancer Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Lung Cancer Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Lung Cancer Drugs Market in Asia & Pacific (2019-2029)
10.1 Lung Cancer Drugs Market Size
10.2 Lung Cancer Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Lung Cancer Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Lung Cancer Drugs Market in Europe (2019-2029)
11.1 Lung Cancer Drugs Market Size
11.2 Lung Cancer Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Lung Cancer Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Lung Cancer Drugs Market in MEA (2019-2029)
12.1 Lung Cancer Drugs Market Size
12.2 Lung Cancer Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Lung Cancer Drugs Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Lung Cancer Drugs Market (2019-2024)
13.1 Lung Cancer Drugs Market Size
13.2 Lung Cancer Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Lung Cancer Drugs Market Size by Type
Chapter 14 Global Lung Cancer Drugs Market Forecast (2024-2029)
14.1 Lung Cancer Drugs Market Size Forecast
14.2 Lung Cancer Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Lung Cancer Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Regeneron Pharmaceuticals/Sanofi
15.1.1 Company Profile
15.1.2 Main Business and Lung Cancer Drugs Information
15.1.3 SWOT Analysis of Regeneron Pharmaceuticals/Sanofi
15.1.4 Regeneron Pharmaceuticals/Sanofi Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.2 Merck
15.2.1 Company Profile
15.2.2 Main Business and Lung Cancer Drugs Information
15.2.3 SWOT Analysis of Merck
15.2.4 Merck Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.3 Bristol-Myers Squibb
15.3.1 Company Profile
15.3.2 Main Business and Lung Cancer Drugs Information
15.3.3 SWOT Analysis of Bristol-Myers Squibb
15.3.4 Bristol-Myers Squibb Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.4 Roche
15.4.1 Company Profile
15.4.2 Main Business and Lung Cancer Drugs Information
15.4.3 SWOT Analysis of Roche
15.4.4 Roche Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.5 AstraZeneca
15.5.1 Company Profile
15.5.2 Main Business and Lung Cancer Drugs Information
15.5.3 SWOT Analysis of AstraZeneca
15.5.4 AstraZeneca Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.6 Pfizer
15.6.1 Company Profile
15.6.2 Main Business and Lung Cancer Drugs Information
15.6.3 SWOT Analysis of Pfizer
15.6.4 Pfizer Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Lung Cancer Drugs Report
Table Data Sources of Lung Cancer Drugs Report
Table Major Assumptions of Lung Cancer Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Lung Cancer Drugs Picture
Table Lung Cancer Drugs Classification
Table Lung Cancer Drugs Applications
Table Drivers of Lung Cancer Drugs Market
Table Restraints of Lung Cancer Drugs Market
Table Opportunities of Lung Cancer Drugs Market
Table Threats of Lung Cancer Drugs Market
Table COVID-19 Impact For Lung Cancer Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Lung Cancer Drugs
Table Cost Structure Analysis of Lung Cancer Drugs
Table Key End Users
Table Latest News of Lung Cancer Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Lung Cancer Drugs Market
Table Policy of Lung Cancer Drugs Market
Table 2019-2029 North America Lung Cancer Drugs Market Size
Figure 2019-2029 North America Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 North America Lung Cancer Drugs Market Size by Application
Table 2019-2024 North America Lung Cancer Drugs Key Players Revenue
Table 2019-2024 North America Lung Cancer Drugs Key Players Market Share
Table 2019-2029 North America Lung Cancer Drugs Market Size by Type
Table 2019-2029 United States Lung Cancer Drugs Market Size
Table 2019-2029 Canada Lung Cancer Drugs Market Size
Table 2019-2029 Mexico Lung Cancer Drugs Market Size
Table 2019-2029 South America Lung Cancer Drugs Market Size
Figure 2019-2029 South America Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 South America Lung Cancer Drugs Market Size by Application
Table 2019-2024 South America Lung Cancer Drugs Key Players Revenue
Table 2019-2024 South America Lung Cancer Drugs Key Players Market Share
Table 2019-2029 South America Lung Cancer Drugs Market Size by Type
Table 2019-2029 Brazil Lung Cancer Drugs Market Size
Table 2019-2029 Argentina Lung Cancer Drugs Market Size
Table 2019-2029 Chile Lung Cancer Drugs Market Size
Table 2019-2029 Peru Lung Cancer Drugs Market Size
Table 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size
Figure 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size by Application
Table 2019-2024 Asia & Pacific Lung Cancer Drugs Key Players Revenue
Table 2019-2024 Asia & Pacific Lung Cancer Drugs Key Players Market Share
Table 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size by Type
Table 2019-2029 China Lung Cancer Drugs Market Size
Table 2019-2029 India Lung Cancer Drugs Market Size
Table 2019-2029 Japan Lung Cancer Drugs Market Size
Table 2019-2029 South Korea Lung Cancer Drugs Market Size
Table 2019-2029 Southeast Asia Lung Cancer Drugs Market Size
Table 2019-2029 Australia Lung Cancer Drugs Market Size
Table 2019-2029 Europe Lung Cancer Drugs Market Size
Figure 2019-2029 Europe Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 Europe Lung Cancer Drugs Market Size by Application
Table 2019-2024 Europe Lung Cancer Drugs Key Players Revenue
Table 2019-2024 Europe Lung Cancer Drugs Key Players Market Share
Table 2019-2029 Europe Lung Cancer Drugs Market Size by Type
Table 2019-2029 Germany Lung Cancer Drugs Market Size
Table 2019-2029 France Lung Cancer Drugs Market Size
Table 2019-2029 United Kingdom Lung Cancer Drugs Market Size
Table 2019-2029 Italy Lung Cancer Drugs Market Size
Table 2019-2029 Spain Lung Cancer Drugs Market Size
Table 2019-2029 Belgium Lung Cancer Drugs Market Size
Table 2019-2029 Netherlands Lung Cancer Drugs Market Size
Table 2019-2029 Austria Lung Cancer Drugs Market Size
Table 2019-2029 Poland Lung Cancer Drugs Market Size
Table 2019-2029 Russia Lung Cancer Drugs Market Size
Table 2019-2029 MEA Lung Cancer Drugs Market Size
Figure 2019-2029 MEA Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 MEA Lung Cancer Drugs Market Size by Application
Table 2019-2024 MEA Lung Cancer Drugs Key Players Revenue
Table 2019-2024 MEA Lung Cancer Drugs Key Players Market Share
Table 2019-2029 MEA Lung Cancer Drugs Market Size by Type
Table 2019-2029 Egypt Lung Cancer Drugs Market Size
Table 2019-2029 Israel Lung Cancer Drugs Market Size
Table 2019-2029 South Africa Lung Cancer Drugs Market Size
Table 2019-2029 Gulf Cooperation Council Countries Lung Cancer Drugs Market Size
Table 2019-2029 Turkey Lung Cancer Drugs Market Size
Table 2019-2024 Global Lung Cancer Drugs Market Size by Region
Table 2019-2024 Global Lung Cancer Drugs Market Size Share by Region
Table 2019-2024 Global Lung Cancer Drugs Market Size by Application
Table 2019-2024 Global Lung Cancer Drugs Market Share by Application
Table 2019-2024 Global Lung Cancer Drugs Key Vendors Revenue
Figure 2019-2024 Global Lung Cancer Drugs Market Size and Growth Rate
Table 2019-2024 Global Lung Cancer Drugs Key Vendors Market Share
Table 2019-2024 Global Lung Cancer Drugs Market Size by Type
Table 2019-2024 Global Lung Cancer Drugs Market Share by Type
Table 2024-2029 Global Lung Cancer Drugs Market Size by Region
Table 2024-2029 Global Lung Cancer Drugs Market Size Share by Region
Table 2024-2029 Global Lung Cancer Drugs Market Size by Application
Table 2024-2029 Global Lung Cancer Drugs Market Share by Application
Table 2024-2029 Global Lung Cancer Drugs Key Vendors Revenue
Figure 2024-2029 Global Lung Cancer Drugs Market Size and Growth Rate
Table 2024-2029 Global Lung Cancer Drugs Key Vendors Market Share
Table 2024-2029 Global Lung Cancer Drugs Market Size by Type
Table 2024-2029 Lung Cancer Drugs Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Regeneron Pharmaceuticals/Sanofi
  • Merck
  • Bristol-Myers Squibb
  • Roche
  • AstraZeneca
  • Pfizer

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Lung Cancer Drugs Market by Disease (Non-Small Cell Lung Cancer, Small Cell Lung cancer), Molecule (Biologics, Small Molecules), Distribution Channel - Forecast 2024-2030 - Product Image

Global Lung Cancer Drugs Market by Disease (Non-Small Cell Lung Cancer, Small Cell Lung cancer), Molecule (Biologics, Small Molecules), Distribution Channel - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Lung Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Lung Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 101 Pages
  • Global
From
Squamous Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Squamous Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 99 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Non-Small Cell Lung Cancer (NSCLC) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.